scholarly journals AYURVEDIC MANAGEMENT OF DIABETES MELLITUS - A SINGLE CASE STUDY

2020 ◽  
Vol 8 (8) ◽  
pp. 4250-4253
Author(s):  
Pandey Mahesh H ◽  
Mule Pranita A

Background: The study was intended to have a theoretical audit of the Madhumeha and its treatment spe-cifically to the utilization of a natural drug Phalatrikadi kwatha. Madhumeha, otherwise called Diabetes Mellitus is one of the sorts of Vataja prameha, that has been considered as an incurable illness (Ma-hagada). Because of extravagance in etiological components it brings about the inadequate arrangement of Kapha and Meda which further continues descending through the channels of Mutravaha srotas and get confined at Basti mukha prompting the side effects like Prabhoota mutrata (polyuria), Avila mutrata (tu-bidity of pee) and so on. As the disease is Chirakari, it requires a compelling treatment which can be pro-ceeded for quite a while with no evil impacts. Among the numerous treatment measures referenced, Phala-trikadi kwath has been chosen in this examination and the impact was assessed. Method: In the current logical examination a 53 years old Male directed in Outpatient having Objections of the patient was increased thirst, frequent urination, hunger, fatigue and blurred vision. By taking a gander at the signs and appearances of complaints of patient was resolved to have Diabetes after exhortation glucose tests reports. In the current case report lenient was required to treat with ayurvedic plan under the treatment of Diabetes. Going to the OPD of YMT Ayurvedic Hospital Kharghar and treated with preliminary medica-tion (Phalatrikadi kwatha). Patients were assessed in a time period for 15 days. FBS, PPBS with clinical sign and manifestations were tested. Result: In the wake of assessing the absolute impacts of the treatment, it was seen that Phalatrikadi kwath alongside diet and routine gave good alleviation. Conclusion: Significant result was observed with this treatment protocol in the management of Madhume-ha.

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1198-1201
Author(s):  
Syed Yasir Afaque

In December 2019, a unique coronavirus infection, SARS-CoV-2, was first identified in the province of Wuhan in China. Since then, it spread rapidly all over the world and has been responsible for a large number of morbidity and mortality among humans. According to a latest study, Diabetes mellitus, heart diseases, Hypertension etc. are being considered important risk factors for the development of this infection and is also associated with unfavorable outcomes in these patients. There is little evidence concerning the trail back of these patients possibly because of a small number of participants and people who experienced primary composite outcomes (such as admission in the ICU, usage of machine-driven ventilation or even fatality of these patients). Until now, there are no academic findings that have proven independent prognostic value of diabetes on death in the novel Coronavirus patients. However, there are several conjectures linking Diabetes with the impact as well as progression of COVID-19 in these patients. The aim of this review is to acknowledge about the association amongst Diabetes and the novel Coronavirus and the result of the infection in such patients.


Author(s):  
Ayu Wulan Dwiputri ◽  
Liza Pristianty ◽  
Andi Hermansyah

AbstractBackgroundThe growing burden of diabetes mellitus (DM) in Southeast Asia puts pharmacists in the ideal position to provide management of DM. This narrative review aims to describe the evidence of pharmacist contribution in improving DM in Southeast Asia.ContentA literature search was conducted to identify relevant research articles published from 2010 to 2018 in four databases (Scopus, Pubmed, MEDLINE, and Springerlink) describing pharmacist roles and activities intended to improve management of DM in Southeast Asian countries. Results were synthesized narratively and divided into three main sections: (1) the role of pharmacist in DM management, (2) the impact of pharmacist role, and (3) the barriers to the implementation of services in DM management. A total of 16 studies were identified, of which ten studies mentioned services that were conducted exclusively by a pharmacist and the remaining collaborated with other health professionals. A number of pharmacist services were reported including prevention, dispensing, medication review, drug information services, patient counselling and education, monitoring, follow-up, and referral. Barriers related to individual, organizational, and public recognition were described.Summary and outlookThe Pharmacist can contribute to improve DM management in a variety of settings. Action research on pharmacist intervention in DM is recommended.


2020 ◽  
Vol 17 ◽  
Author(s):  
Nihad Al-hashimi ◽  
Mai Babenko ◽  
Maria Saaed ◽  
Negeen Kargar ◽  
Amr ElShaer

: Diabetes mellitus is one of the long known chronic diseases, today over 400 million people are diagnosed with diabetes. Yet curing diabetes is a challenge. Over the decades, the approaches of treating diabetes mellitus have evolved and polymeric materials have played an integral part in developing and manufacturing anti-diabetic medications. However, injection of insulin remains the conventional therapy for the treatment of diabetes. Oral administration is generally the most preferred route; yet, physiological barriers lead to a challenge for the formulation development for oral delivery of antidiabetic peptide and protein drugs. This present review focuses on the role of different types of biodegradable polymers (e.g., synthetic and natural) that have been used to develop micro and nano particles based formulations for antidiabetic drugs (Type 1 and Type 2) and how the various encapsulation strategies impact its therapeutic effect, including pharmacokinetics studies, drug release profiles and efficacy of the encapsulated drugs. This review also includes studies of different dosage forms such as oral, nasal, inhalation and sublingual for the treatment of diabetes that have been investigated using synthetic and natural biodegradable polymers in order to develop an alternative route to subcutaneous route for a better control of serum glucose levels.


1999 ◽  
Vol 138 (4) ◽  
pp. s334-s337 ◽  
Author(s):  
S RAO ◽  
A BETHEL ◽  
M FEINGLOS

2009 ◽  
Vol 37 (05) ◽  
pp. 314-318 ◽  
Author(s):  
L. Keller ◽  
K. Meichner ◽  
S. Unterer ◽  
K. Hartmann ◽  
I. Zenker

Summary Objective: Severe thrombocytopenia is a common sequelae to heat stroke in dogs. So far it has been hypothezised that it is due to disseminated intravascular coagulation. We hypothezised that it is due to immune mediated destruction via antiplatelet antibodies. Material and methods: Prospective evaluation of dogs with heat stroke from May 2005 to August 2008. Dogs that developed severe thrombocytopenia within 5 days of admission were included in the study. All dogs were treated with a standardized treatment protocol. In addition, they received either immunoglobulins or prednisolone. Results: Six dogs were presented with heat stroke during that time period. Four developed a severe thrombocytopenia. All four dogs tested positive for antiplatelet antibodies and did not have elevated D-Dimers at that time. Platelet count in three dogs recovered fully, one dog was euthanized due to liver and renal failure. Conclusion: In those cases thrombocytopenia was due to immune mediated destruction not due to DIC. Clinical rele-vance: Due to the severity of the thrombocytopenia and the high risk for bleeding in those patients, immunosuppressive therapy in addition to DIC prophylaxis should be discussed.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1612-P
Author(s):  
NADIRA SULTANA KAKOLY ◽  
ARUL EARNEST ◽  
HELENA TEEDE ◽  
LISA MORAN ◽  
DEBORAH LOXTON ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2293-PUB ◽  
Author(s):  
VEERANNA KARADI ◽  
DILIP PAWAR ◽  
SARAH JABEEN ◽  
SANDEEP S. ◽  
SAPTARSHI BOSE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document